Cabotib 20 Tablet
By Cabotib
Rx
30 Tablet in a Bottle

Composition
Cabozantinib(20mg)

Manufacturer - Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.

Expires on or after
July, 2025

liver
Cabotib 20 Tablet should be used carefully in individuals with liver disease. It may be necessary to adjust the dose of Cabotib 20 Tablet, so it is important to seek advice from your doctor. If you have a pre-existing liver condition or a history of liver problems, inform your doctor before starting this medication. Cabotib 20 mg Tablet 30's has the potential to cause liver damage when used alongside nivolumab. Therefore, caution is advised when using this medication in patients with moderate liver impairment. Your doctor may recommend liver function tests to monitor the impact of the treatment on your liver.

kidney
Cabotib 20 Tablet is safe for use in patients with kidney disease. Inform your doctor if you have kidney issues before taking this medicine; dosage adjustment may be needed.

alcohol
It is advisable to avoid alcohol while taking Cabotib 20 Tablet as it may lead to severe side effects. Always consult your doctor for guidance.

driving
It is not clear if Cabotib 20 Tablet affects driving ability. Avoid driving if you have symptoms affecting focus and reactions. Cabotib 20 mg Tablet 30's may cause dizziness and vision issues, so avoid driving until sure it's safe.

pregnancy
Cabotib 20 Tablet may not be safe to use during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing this medication. It is important to consult your doctor, especially if you are pregnant or planning to become pregnant, as Cabotib 20 Tablet may cause harm to the fetus. Effective birth control methods should be used while taking this medication, and it is advised not to get pregnant for at least four months after discontinuing Cabotib 20 Tablet.

breastfeeding
Cabotib 20 Tablet may be unsafe during breastfeeding as it can pass into breastmilk and harm the baby. Avoid nursing while on this medication and for at least four months after the last dose. It is advisable to consult your doctor before using Cabotib 20 Tablet.
Habit Forming | No |
Chemical Class | Diarylethers |
Therapeutic Class | - |
Action Class | Tyrosine kinase inhibitors |
₹4900
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024